Table 2.
Risk factors for early recurrence
| Variable | Univariate Analysis, p value | Multivariable Analysis | ||
|---|---|---|---|---|
| p Value | Odds Ratio | 95% CI | p Value | |
| Age(years) | 0.987 | |||
| Sex | 0.458 | |||
| Female | ||||
| Male | ||||
| BMI | 0.454 | |||
| ALB | 0.920 | |||
| HB | 0.511 | |||
| Tumor size(cm) | 0.422 | |||
| Tumor location (Others VS Head) | 0.012 | 1.86 | 0.65–5.37 | 0.25 |
| Preoperative CA-199 | 0.139 | |||
| Preoperative CA-125 (>26.95 VS <26.95) | <0.001 | 5.47 | 1.83–16.4 | 0.002 |
| Preoperative CEA | 0.691 | |||
| Histological type | 0.965 | |||
| Well-mod. adenocarcinoma | ||||
| Poor adenocarcinoma | ||||
| Others | ||||
| Pathological vascular invasion (yes vs. no) | <0.001 | 9.27 | 2.51–34.23 | 0.001 |
|
Positive lymph nodes (yes vs. no) |
<0.001 | 4.18 | 1.52–11.5 | 0.006 |
|
Chemotherapy regimens (mF vs. AG) |
0.018 | 4.2 | 0.56–31.68 | 0.164 |
| TBCAS(day) | 0.404 | |||
BMI: Body Mass Index; HB: hemoglobin; ALB: albumin; TBCAS: Time to beginning chemotherapy after surgery; TBCAS: Time to begin chemotherapy after surgery